Loading...
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
INTRODUCTION: There are no determined treatment agents for severe COVID-19. It is suggested that methylprednisolone, as an immunosuppressive treatment, can reduce the inflammation of the respiratory system in COVID-19 patients. METHODS: We conducted a single-blind, randomised controlled clinical tri...
Na minha lista:
Udgivet i: | Eur Respir J |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
European Respiratory Society
2020
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7758541/ https://ncbi.nlm.nih.gov/pubmed/32943404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02808-2020 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|